CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2023 GI Fellow Board of Advisors
Embassy of Education
Slide Library Webcasts Annotations Abstract Library Committee Members
 
HBV-Single Disease Content  
Featured Article


Webcasts
     
HBV/HDV-ACT Connect (ADVANCING CURATIVE TREATMENTS)   Educational Webcast
Hepatitis B and D Infection   Educational Webcast
HBV/HDV Hot Topics & Virtual Roundtable   Educational Webcast
HBV, HCV, and HDV   Educational Webcast
 
 
Slide Library
   Released: 2023
Webcast
Stopping All Therapy in HBV Clinical Trials: What Should Be the Criteria for Discontinuation
23 slides
 
 
   Released: 2023
Webcast
New Insights Into The Biology Of HDV: Implications For Drug Development
42 slides
 
 
   Released: 2023
Webcast
HBV Overview of the Last 3 Years For Drug Development: Phase 2 Trials
43 slides
 
 
   Released: 2023
Webcast
Emerging Therapies for HBV in the Next Three Years (Pre-clinical to Phase 1)
31 slides
 
 
   Released: 2023
Webcast
What Are the Most Promising Immunomodulatory Therapies for HBV Infection?
29 slides
 
 
   Released: 2023
Webcast
Emerging Concepts and Data CpAMS Third and Fourth Generation
33 slides
 
 
   Released: 2023
Webcast
Does the New Data on HBV DNA Integration and HBsAg Production Effect the Design and Definition of Treatment Endpoints of Phase II and Phase III Studies?
20 slides
 
 
   Released: 2023
Webcast
Is there a real difference between ETV and TDF/TAF in relapse and HCC?
27 slides
 
 
   Released: 2023
Webcast
How Do We Fit FNA and Liver Biopsy Into HBV Drug Development and Design? Should All Studies Have FNA Subset and Examine Intrahepatic Immune Activity? CccDNA? Integrants?
19 slides
 
 
   Released: 2023
Webcast
Should All Patients With HDV Be Treated?
22 slides
 
 
   Released: 2023
Webcast
HDV Update: Review of the Last 3 Years
18 slides
 
 
   Released: 2023
Webcast
Hepatitis Delta: How Should Bulevirtide Be Used in Clinical Practice
27 slides
 
 
   Released: 2023
Webcast
What Other Therapies Are Being Developed for HDV Infection? NAPS, Lambda, and Lonafarnib
36 slides
 
 
   Released: 2023
Webcast
What Is the Role of Interferon Therapy in HDV?
30 slides
 
 
   Released: 2021
Webcast
HBV Alliance: Expert Recommendations on Managing Patients with Chronic Hepatitis B
56 slides
 
 
   Released: 2021
Webcast
Acute HBV
17 slides
 
 
   Released: 2021
Webcast
Chemotherapy/Reactivation
26 slides
 
 
   Released: 2021
Webcast
Current Management of Chronic Hepatitis B
30 slides
 
 
   Released: 2021
Webcast
Epidemiology of HBV
34 slides
 
 
   Released: 2021
Webcast
Evaluation of the Patient With Chronic HBV
26 slides
 
 
   Released: 2021
Webcast
Everything Old Is New Again!
41 slides
 
 
   Released: 2021
Webcast
Extrahepatic Manifestations of Hepatitis B
34 slides
 
 
   Released: 2021
Webcast
HBsAg Quant HBV Genotyping HBV RNA Quant Where We Are in 2020
41 slides
 
 
   Released: 2021
Webcast
HBV & Hepatitis D (Delta)
26 slides
 
 
   Released: 2021
Webcast
HBV and Liver Cancer
34 slides
 
 
   Released: 2021
Webcast
HBV and NAFLD
35 slides
 
 
   Released: 2021
Webcast
HBV Coinfection With HCV or HIV
35 slides
 
 
   Released: 2021
Webcast
HBV: New Therapies & Clinical Trials
37 slides
 
 
   Released: 2021
Webcast
Hepatitis B Screening: CDC, AASLD, USPSTF
24 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Treatment Endpoints
27 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Update on Treatment Guidelines
27 slides
 
 
   Released: 2021
Webcast
How to Diagnose Hepatitis B
25 slides
 
 
   Released: 2021
Webcast
Immunization for HBV
31 slides
 
 
   Released: 2021
Webcast
Management of HBV: New Data
26 slides
 
 
   Released: 2021
Webcast
Natural History of HBV
39 slides
 
 
   Released: 2021
Webcast
Treatment of Hepatitis B: Controversies 2020
63 slides
 
 
   Released: 2021
Webcast
Update on Hepatitis B
54 slides
 
 
   Released: 2021
Webcast
WHO Hepatitis Elimination Targets
46 slides
 
 
   
     
 
 
 
Annotated Bibliography
 
 
 
Abstract Library
1.A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug
 

Cureus. 2023 Jul 24;15(7):e42367. doi: 10.7759/cureus.42367. eCollection 2023 Jul.

 

Santhosh Raja Thangaraj 1, Mirra Srinivasan 2 3, Hadia Arzoun 2 3, Siji S Thomas 2
 
2.Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older
 

Ann Hepatol. 2023 Jun 10;28(5):101126. doi: 10.1016/j.aohep.2023.101126. Online ahead of print.

 

Muhammad A Mujtaba 1, Ann Kathleen Gamilla-Crudo 2, Shehzad N Merwat 2, Syed A Hussain 2, Michael Kueht 2, Aftab Karim 3, Muhammad W Khattak 4, Peggy J Rooney 5, Khurram Jamil 5
 
3.High-normal versus low-normal mean arterial pressure thresholds in critically ill patients: a systematic review and meta-analysis of randomized trials
 

Can J Anaesth. 2023 Jul;70(7):1244-1254. doi: 10.1007/s12630-023-02494-3.Epub 2023 Jun 2.

 

Kiran J K Rikhraj 1 2, Claire Ronsley 3, Mypinder S Sekhon 4, Anish R Mitra 4, Donald E G Griesdale 4 5 6
 
4.The progression of hepatorenal syndrome-acute kidney injury in acute alcohol-associated hepatitis: renal outcomes after liver transplant
 

Therap Adv Gastroenterol. 2023 Jul 31;16:17562848231188813.doi: 10.1177/17562848231188813. eCollection 2023.

 

Alessandro Colletta 1, Katherine M Cooper 2, Deepika Devuni 3
 
5.Acute Kidney Injury in Liver Cirrhosis
 

Diagnostics (Basel). 2023 Jul 13;13(14):2361. doi: 10.3390/diagnostics13142361.

 

Rose Mary Attieh 1, Hani M Wadei 1
 
6.Renal damage in Hepatorenal Syndrome: A still unsolved issue
 

Clin Res Hepatol Gastroenterol. 2023 Jul 14;47(7):102178.doi: 10.1016/j.clinre.2023.102178. Online ahead of print.

 

Alberto Calleri 1, Carlo Alessandria 2
 
7.Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury
 

Hepatology. 2023 May 1;77(5):1630-1638. doi: 10.1002/hep.32799. Epub 2023 Apr 17.

 

Carmine Gambino 1, Salvatore Piano 1, Matteo Stenico 1, Marta Tonon 1, Alessandra Brocca 1, Valeria Calvino 1, Simone Incicco 1, Nicola Zeni 1, Roberta Gagliardi 1, Chiara Cosma 2, Martina Zaninotto 2, Patrizia Burra 3, Umberto Cillo 4, Daniela Basso 2, Paolo Angeli 1
 
8.Outcomes of patients with hepatorenal syndrome undergoing liver transplantation in the era of terlipressin
 

Eur J Gastroenterol Hepatol. 2023 Aug 1;35(8):881-888.doi: 10.1097/MEG.0000000000002584. Epub 2023 Jun 6.

 

Ryma Terbah 1 2, Janet Cao 1 2, Darren Wong 1 2, Peter Chee Hau Lim 1, Paul Gow 1 2, Adam Testro 1 2, Marie Sinclair 1 2
 
9.Recent advances in pathophysiology, diagnosis and management of hepatorenal syndrome: A review
 

World J Hepatol. 2023 Jun 27;15(6):741-754. doi: 10.4254/wjh.v15.i6.741.

 

Calvin Kiani 1, Andreas G Zori 2
 
10.Update on Assessment of Estimated Glomerular Filtration Rate in Patients With Cirrhosis
 

Adv Kidney Dis Health. 2023 Jun 30;S2949-8139(23)00058-7.doi: 10.1053/j.akdh.2023.06.001. Online ahead of print.

 

Connor Griffin 1, Sumeet K Asrani 1, Kevin R Regner 2
 
11.Kidney disease in patients with chronic liver disease: Does sex matter?
 

World J Clin Cases. 2023 Jun 16;11(17):3980-3992. doi: 10.12998/wjcc.v11.i17.3980.

 

Katherine M Cooper 1, Alessandro Colletta 2, Kristen Moulton 3, Kenneth M Ralto 4, Deepika Devuni 3
 
12.Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management
 

Ann Pharmacother. 2023 Jun 4;10600280231177698.doi: 10.1177/10600280231177698. Online ahead of print.

 

Brian L Erstad 1
 
13.Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical Trial
 

JAMA. 2023 May 9;329(18):1558-1566.doi: 10.1001/jama.2023.4902.

Alexandre Louvet 1, Julien Labreuche 2, Thong Dao 3, Thierry Thévenot 4, Frédéric Oberti 5, Christophe Bureau 6, Thierry Paupard 7, Eric Nguyen-Khac 8, Anne Minello 9, Brigitte Bernard-Chabert 10, Rodolphe Anty 11, Faustine Wartel 12, Nicolas Carbonell 13, Georges-Philippe Pageaux 14, Marie-Noelle Hilleret 15, Romain Moirand 16, Pierre Nahon 17, Camille Potey 18, Alain Duhamel 2, Philippe Mathurin 1
 
14.Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension
 

Liver Int. 2023 Jun;43(6):1183-1194. doi: 10.1111/liv.15559. Epub 2023 Apr 17.

Laura Turco 1, Thomas Reiberger 2 3, Giovanni Vitale 1, Vincenzo La Mura 4 5
 
15.Diagnosis and Management of Cirrhosis and Its Complications: A Review
 

JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997.

Elliot B Tapper 1, Neehar D Parikh 1
 
16.Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis
 

Am J Health Syst Pharm. 2023 Apr 4;zxad070. doi: 10.1093/ajhp/zxad070. Online ahead of print.

Marcelo Kugelmas 1, Michelle Loftus 2, Emily J Owen 3, Hani Wadei 4, Sammy Saab 5
 
17.Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment
 

Med Clin North Am. 2023 Jul;107(4):781-792. doi: 10.1016/j.mcna.2023.03.009.Epub 2023 Apr 20.

Justin M Belcher 1
 
18.The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
 

Kidney360. 2023 May 5. doi: 10.34067/KID.0000000000000132. Online ahead of print.

Juan Carlos Q Velez 1 2, Florence Wong 3, K Rajender Reddy 4, Arun J Sanyal 5, Hugo E Vargas 6, Michael P Curry 7, Stevan A Gonzalez 8, S Chris Pappas 9, Khurram Jamil 10
 
19.Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome
 

Cleve Clin J Med. 2023 Apr 3;90(4):209-213. doi: 10.3949/ccjm.90a.22028.

Sarah Khan 1, Maureen Linganna 2
 
20.Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial
 

Trials. 2023 Apr 5;24(1):258.doi: 10.1186/s13063-023-07261-9.

Cristina Ripoll 1, Stephanie Platzer 2, Philipp Franken 2, Rene Aschenbach 3, Andreas Wienke 4, Ulrike Schuhmacher 2, Ulf Teichgräber 3, Andreas Stallmach 5, Jörg Steighardt 6, Alexander Zipprich 5; Liver-HERO Study Group
 
21.Outcomes, Mortality, and Cost Burden of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis
 

J Gastrointestin Liver Dis. 2023 Mar 31;32(1):39-50. doi: 10.15403/jgld-4618.

Ankoor Patel 1, Clark Zhang 2, Carlos D Minacapelli 3, Kapil Gupta 4, Carolyn Catalano 5, You Li 6, Vinod K Rustgi 7
 
22.Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
 

Crit Care Explor. 2023 Mar 28;5(4):e0890. doi: 10.1097/CCE.0000000000000890.eCollection 2023 Apr.

Constantine J Karvellas 1, Ram Subramanian 2, Jody C Olson 3, Khurram Jamil 4
 
23.Clinical determinants of hospital mortality in liver failure: a comprehensive analysis of 62,717 patients
 

 Gastroenterol. 2023 Mar 27. doi: 10.1055/a-2016-9061. Online ahead of print.

Tobias Essing 1 2, Hans Bock 1, Björn Wieland 1, Georg Fluegen 3, Jan Bednarsch 4, Johannes G Bode 1, Ulf P Neumann 4, Christoph Roderburg 1, Sven H Loosen # 1, Tom Luedde # 1
 
24.Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences
 

Med Clin North Am. 2023 May;107(3):505-516. doi: 10.1016/j.mcna.2022.12.004.Epub 2023 Feb 20.

Marta Tonon 1, Salvatore Piano 2
 
25.Renal Insufficiency in Patients with Cirrhosis
 

Clin Liver Dis. 2023 Feb;27(1):57-70. doi: 10.1016/j.cld.2022.08.010.Epub 2022 Oct 18.

Caroline L Matchett 1, Douglas A Simonetto 2, Patrick S Kamath 3
 
View More
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.